EDGAR Filing Documents for 0001193125-07-061689

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-07-061689

Filing Date

2007-03-22

Accepted

2007-03-22 16:25:42

Documents

Period of Report

2006-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1108632
2	THIRD LEASE AMENDMENT BY AND BETWEEN THE COMPANY AND WFUHS	dex102d.htm	EX-10.2(D)	56961
3	EXCLUSIVE LICENSE AGREEMENT	dex1020.htm	EX-10.20	96633
4	MODIFIED AIA DOCUMENT B141	dex1021.htm	EX-10.21	626360
5	MODIFIED AIA DOCUMENT A111	dex1022.htm	EX-10.22	862256
6	DESCRIPTION OF ANNUAL CASH INCENTIVE PROGRAM	dex1023.htm	EX-10.23	2982
7	DESCRIPTION OF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM	dex1024.htm	EX-10.24	6499
8	CONSENT OF ERNST & YOUNG LLP	dex231.htm	EX-23.1	1417
9	CERTIFICATION OF CEO PURSUANT TO SECTION 302	dex311.htm	EX-31.1	5947
10	CERTIFICATION OF CFO PURSUANT TO SECTION 302	dex312.htm	EX-31.2	5878
11	CERTIFICATION OF CEO PURSUANT TO SECTION 906	dex321.htm	EX-32.1	3304
12	CERTIFICATION OF CFO PURSUANT TO SECTION 906	dex322.htm	EX-32.2	3325
13	GRAPHIC	g95961img003.jpg	GRAPHIC	14340
	Complete submission text file	0001193125-07-061689.txt		2801475

Mailing Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101

Business Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101 3364802100

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 000-51173 | Film No.: 07712199
SIC: 2834 Pharmaceutical Preparations